# Foresite Capital Management VI LLC: Form 13F holdings

An institutional investment manager in WEST HOLLYWOOD, CA. SEC CIK 2013341.

- Quarter ended: 2026-06-30
- Filed: 2026-08-14
- Reported value: $642.6m
- Positions: 23 (23 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/2013341/000110465926097133/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [CG Oncology, Inc. (CGON)](/companies/cgon.md) | COM | $168.4m | 26.2% | 2,369,574 |  | Added +148,100 |
| [ALUMIS INC. (ALMS)](/companies/alms.md) | COM | $119.5m | 18.6% | 4,247,670 |  | Unchanged |
| [Seaport Therapeutics, Inc. (SPTX)](/companies/sptx.md) | COM | $38.7m | 6.0% | 1,779,521 |  | New +1,779,521 |
| [Denali Therapeutics Inc. (DNLI)](/companies/dnli.md) | COM | $35.9m | 5.6% | 1,396,771 |  | Added +186,800 |
| [Celldex Therapeutics, Inc. (CLDX)](/companies/cldx.md) | COM | $32.7m | 5.1% | 879,713 |  | Added +563,800 |
| [AGIOS PHARMACEUTICALS, INC. (AGIO)](/companies/agio.md) | COM | $29.1m | 4.5% | 785,000 |  | Added +260,000 |
| [Corvus Pharmaceuticals, Inc. (CRVS)](/companies/crvs.md) | COM | $27.4m | 4.3% | 1,831,233 |  | Unchanged |
| [Parabilis Medicines, Inc. (PBLS)](/companies/pbls.md) | COM | $27.3m | 4.3% | 999,044 |  | New +999,044 |
| GH Research PLC | ORD | $25.3m | 3.9% | 940,493 |  | Added +625,001 |
| [Jade Biosciences, Inc. (JBIO)](/companies/jbio.md) | COM | $19.7m | 3.1% | 886,667 |  | Added +566,667 |
| [Hinge Health, Inc. (HNGE)](/companies/hnge.md) | CL A | $18.3m | 2.8% | 220,400 |  | Unchanged |
| [Kymera Therapeutics, Inc. (KYMR)](/companies/kymr.md) | COM | $16.8m | 2.6% | 146,332 |  | Unchanged |
| AtaiBeckley Inc. | COM | $14.5m | 2.3% | 2,750,000 |  | Unchanged |
| [Verastem, Inc. (VSTM)](/companies/vstm.md) | COM | $12.0m | 1.9% | 3,146,631 |  | Unchanged |
| [Beam Therapeutics Inc. (BEAM)](/companies/beam.md) | COM | $11.3m | 1.8% | 330,000 |  | New +330,000 |
| [Minerva Neurosciences, Inc. (NERV)](/companies/nerv.md) | COM | $11.0m | 1.7% | 1,985,584 |  | Reduced −1,016 |
| [ArriVent BioPharma, Inc. (AVBP)](/companies/avbp.md) | COM | $10.5m | 1.6% | 301,341 |  | New +301,341 |
| [Aura Biosciences, Inc. (AURA)](/companies/aura.md) | COM | $9.5m | 1.5% | 1,333,334 |  | New +1,333,334 |
| Crinetics Pharmaceuticals, Inc. | COM | $7.9m | 1.2% | 212,010 |  | Unchanged |
| Research Alliance Corp III | CL A | $3.2m | 0.5% | 300,000 |  | New +300,000 |
| Zura Bio Ltd | CL A | $2.7m | 0.4% | 450,000 |  | Unchanged |
| [Kailera Therapeutics, Inc. (KLRA)](/companies/klra.md) | COM | $826.1k | 0.1% | 37,500 |  | New +37,500 |
| [Disc Medicine, Inc. (IRON)](/companies/iron.md) | COM | $70.9k | <0.1% | 970 |  | New +970 |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| Centessa Pharmaceuticals plc | SPONSORED ADS | $0 | 0.0% | 0 |  | Sold out −1,364,019 |
| [OnKure Therapeutics, Inc. (OKUR)](/companies/okur.md) | COM CL A | $0 | 0.0% | 0 |  | Sold out −1,445,783 |

Source: SEC EDGAR, Form 13F-HR, accession 0001104659-26-097133. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.